Literature DB >> 4197955

Anticonvulsant drugs in human epileptogenic brain. Correlation of phenobarbital and diphenylhydantoin levels with plasma.

A L Sherwin, A A Wisen, C D Sokolowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4197955     DOI: 10.1001/archneur.1973.00490260017001

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  20 in total

Review 1.  Pharmacokinetic considerations in the treatment of childhood epilepsy.

Authors:  Jamie T Gilman; Michael Duchowny; Ana E Campo
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

2.  The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.

Authors:  E H Reynolds
Journal:  Proc R Soc Med       Date:  1975-02

3.  Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Authors:  J T Gilman; P Gal
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.

Authors:  P M Loughnan; A Greenwald; W W Purton; J V Aranda; G Watters; A H Neims
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

Review 5.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 6.  Disposition of anticonvulsants in childhood.

Authors:  J I Morrow; A Richens
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

7.  Folic acid deficiency and epilepsy.

Authors:  J W Norris; R F Pratt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

8.  Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.

Authors:  M L Friis; J Christiansen; E F Hvidberg
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

9.  Differences between the concentrations of antiepileptic drugs in normal and pathological human brain.

Authors:  V A Sironi; L Ravagnati; G Ettorre; G P Cabrini; F Marossero
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Barbitone-induced tolerance to the effects of sedative-hypnotics and related compounds on operant behaviour in the rat.

Authors:  J M Carney; J A Rosecrans; M R Vasko
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.